Font Size:
a
A
A
Keyword [HER2-positive]
Result: 1 - 20 | Page: 1 of 6
1.
The Molecular Mechanism And RNAi Research About HER2 Positive Metastatic Gastric Cancer
2.
Gene Construction, Expression, Purification And Targeted Killing Of Immunoproapoptotic Molecule E23sFv-TD-tBID Against HER2 Positive Carcinoma
3.
The Mechanism Of Apoptosis Induced By Lapatinib In Her2 Positive Breast Cancer Cells And Synergistic Effective Between ABT-737 And Lapatinib
4.
Gene Construction, Expression And Antitumor Effect Of Recombinant Immuno-tBid Molecules With Different Translocation Peptides On HER2 Positive Carcinoma
5.
Contrastive Analysis Of Clinicopathologic Features And Prognosis Between Triple Negative Breast Cancer And HR Negative/HER2 Positive Breast Cancer
6.
Expressions Of TopoⅡa Protein And Multivariate Analysis Of Survival Rates For HER2 Positive Breast Carcinoma
7.
Novel Role Of MiR-375in Trastuzumab-resistance And Metastasis Of HER2-positive Breast Cancer
8.
Study On AG490-enhanced Trastuzumab Sensitivity In HER2-positive Breast Cancer Cells
9.
Study On The Role Of PRAS40 Phosphorylation At Thr246 In The Development Of Trastuzumab Resistance In HER2-positive Breast Cancer
10.
Clinical Significance Of Circulating Tumor DNA Detection In HER2 Positive Advanced Breast Cancer Patients Treated With Target Therapy
11.
A Research On Drug-resistant Mutations In HER2-positive Breast Cancer Based On Circulating Tumor DNA And CRISPR/cas9 Technique
12.
Studies On Prognostic Prediction In HER2 Positive Breast Cancer And Treatment In Triple Negative Breast Cancer
13.
MicroRNA-608Impacts Susceptibility And Progress Of HER2-positive Breast Cancer
14.
Significance And Clinical And Pathological Features Of Akt2and HER2Protein Expression In Gastric Cancer
15.
FW-04-806, A Macrolide Dilactone Compound, Shows Potent Efficacy Against HER2-positive Gastric Cancer Cell Lines
16.
The Optimization Of Maintenance Treatment And A Exploratory Research Of HER2 Positive Metastatic Breast Cancer With Detection By CtDNA
17.
Mechanism And Functional Research Of Autophagy Promoting Lapatinib Resistance Of HER2-Positive Breast Cancer Cells
18.
Experimental Animal Study Of DCIK-Her2 Cell Anti-tumor Effect In Her2 Positive Breast Cancer
19.
Research On The Paclitaxel/Lapatinib-loaded PEG-PLA Micelles For The Treatment Of HER2 Positive Breast Cancers
20.
Ⅰ-Ⅱ Phase HER2 Positive Breast Cancer Neoadjuvant Therapy Efficacy And The Related Clinical Pathologic Factors Of Prospective Studies
<<First
<Prev
Next>
Last>>
Jump to